000 | 01960 a2200493 4500 | ||
---|---|---|---|
005 | 20250515122941.0 | ||
264 | 0 | _c20080909 | |
008 | 200809s 0 0 eng d | ||
022 | _a1537-6591 | ||
024 | 7 |
_a10.1086/589250 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMurray, Maeve P | |
245 | 0 | 0 |
_aOutcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection. _h[electronic resource] |
260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cJul 2008 |
||
300 |
_a222-4 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
650 | 0 | 4 | _aBlood Sedimentation |
650 | 0 | 4 |
_aCiprofloxacin _xadministration & dosage |
650 | 0 | 4 |
_aClarithromycin _xadministration & dosage |
650 | 0 | 4 | _aDrug Resistance, Bacterial |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aEthambutol _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung _xdiagnostic imaging |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMycobacterium Infections, Nontuberculous _xdiagnosis |
650 | 0 | 4 |
_aMycobacterium avium _xdrug effects |
650 | 0 | 4 |
_aMycobacterium avium-intracellulare Infection _xdiagnosis |
650 | 0 | 4 |
_aNontuberculous Mycobacteria _xdrug effects |
650 | 0 | 4 | _aRadiography |
650 | 0 | 4 |
_aRifampin _xadministration & dosage |
650 | 0 | 4 |
_aSputum _xmicrobiology |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdiagnosis |
700 | 1 | _aLaurenson, Ian F | |
700 | 1 | _aHill, Adam T | |
773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 47 _gno. 2 _gp. 222-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1086/589250 _zAvailable from publisher's website |
999 |
_c18019035 _d18019035 |